Severe hyponatremia is a better predictor of mortality than MELDNa in patients with cirrhosis and refractory ascites

Journal of Hepatology

Volumn 57, Issue 2, 2012, Pages 274-280

  Sersté, Thomas ^a,b   Gustot, Thierry ^a,c   Rautou, Pierre Emmanuel ^a,d   Francoz, Claire ^a,d,e   Njimi, Hassane ^f   Durand, Francois ^a,d,e   Valla, Dominique ^a,d,e   Lebrec, Didier ^a,d,e   Moreau, Richard ^a,d,e  

^a BEAUJON HOSPITAL   (France)

^b SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

^c ERASME HOSPITAL   (Belgium)

^d CENTRE DE RECHERCHE BIOMÉDICALE BICHAT BEAUJON CRB3   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Cirrhosis; MELDNa score; Prognostic factors; Refractory ascites; Serum sodium

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; SODIUM;

ADULT; AREA UNDER THE CURVE; ARTICLE; ASCITES; CHILD PUGH SCORE; FEMALE; HUMAN; HYPONATREMIA; INCIDENCE; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MELDNA SCORE; MORTALITY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OBSERVATIONAL STUDY; PARACENTESIS; PREDICTOR VARIABLE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; REFRACTORY PERIOD; SODIUM BLOOD LEVEL;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; ASCITES; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPONATREMIA; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SODIUM;

EID: 84863981075     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2012.03.018     Document Type: Article

References (25)

1. V. Arroyo, P. Gines, A.L. Gerbes, F.J. Dudley, P. Gentilini, and G. Laffi Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis Int Ascites Club Hepatol 23 1996 164 176
2. K.P. Moore, F. Wong, P. Gines, M. Bernardi, A. Ochs, and F. Salerno The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club Hepatology 38 2003 258 266
3. R. Moreau, P. Delegue, F. Pessione, S. Hillaire, F. Durand, and D. Lebrec Clinical characteristics and outcome of patients with cirrhosis and refractory ascites Liver Int 24 2004 457 464
4. F. Salerno, C. Camma, M. Enea, M. Rossle, and F. Wong Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data Gastroenterology 133 2007 825 834
5. M. Malinchoc, P.S. Kamath, F.D. Gordon, C.J. Peine, J. Rank, and P.C. ter Borg A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts Hepatology 31 2000 864 871
6. P.S. Kamath, and W.R. Kim The model for end-stage liver disease (MELD) Hepatology 45 2007 797 805
7. D.M. Heuman, S.G. Abou-Assi, A. Habib, L.M. Williams, R.T. Stravitz, and A.J. Sanyal Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death Hepatology 40 2004 802 810
8. M. Bernardi, S. Gitto, and M. Biselli The MELD score in patients awaiting liver transplant: Strengths and weaknesses J Hepatol 54 2011 1297 1306
9. M.C. Londono, A. Cardenas, M. Guevara, L. Quinto, D. de Las Heras, M. Navasa, and A. Rimola MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation Gut 56 2007 1283 1290
10. A. Luca, B. Angermayr, G. Bertolini, F. Koenig, G. Vizzini, and M. Ploner An integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cirrhosis Liver Transpl 13 2007 1174 1180
11. S.W. Biggins, and K. Bambha MELD-based liver allocation: who is underserved? Semin Liver Dis 26 2006 211 220
12. S.W. Biggins, W.R. Kim, N.A. Terrault, S. Saab, V. Balan, and T. Schiano Evidence-based incorporation of serum sodium concentration into MELD Gastroenterology 130 2006 1652 1660
13. S.W. Biggins, H.J. Rodriguez, P. Bacchetti, N.M. Bass, J.P. Roberts, and N.A. Terrault Serum sodium predicts mortality in patients listed for liver transplantation Hepatology 41 2005 32 39
14. W.R. Kim, S.W. Biggins, W.K. Kremers, R.H. Wiesner, P.S. Kamath, and J.T. Benson Hyponatremia and mortality among patients on the liver-transplant waiting list N Engl J Med 359 2008 1018 1026
15. D. Samuel MELD-Na as a prognostic score for cirrhotic patients: hyponatremia and ascites are back in the game J Hepatol 50 2009 836 838
16. T. Sersté, C. Melot, C. Francoz, F. Durand, P.E. Rautou, and D. Valla Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites Hepatology 52 2010 1017 1022
17. P. Gines, and M. Guevara Hyponatremia in cirrhosis: pathogenesis, clinical significance, and management Hepatology 48 2008 1002 1010
18. D.A. Southern, P.D. Faris, and R. Brant Kaplan-Meier methods yielded misleading results in competing risk scenarios J Clin Epidemiol 59 2006 1110 1114
19. R.J. Gray A class of k-sample tests for comparing the cumulative incidence of a competing risk Ann Stat 16 1988 1141 1154
20. F. Salerno, M. Merli, O. Riggio, M. Cazzaniga, V. Valeriano, and M. Pozzi Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites Hepatology 40 2004 629 635
21. M. Rössle, A. Ochs, V. Gülberg, V. Siegerstetter, J. Holl, and P. Deibert A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites N Engl J Med 342 2000 1701 1707
22. P. Angeli, F. Wong, H. Watson, and P. Gines Hyponatremia in cirrhosis: results of a patient population survey Hepatology 44 2006 1535 1542
23. M. Somsouk, J. Guy, S.W. Biggins, E. Vittinghoff, M.A. Kohn, and J.M. Inadomi Ascites improves upon serum sodium plus model for end-stage liver disease (MELD) for predicting mortality in patients with advanced liver disease Aliment Pharmacol Ther 30 2009 741 748
24. M.D. Leise, W.R. Kim, W.K. Kremers, J.J. Larson, J.T. Benson, and T.M. Therneau A revised model for end-stage liver disease optimizes prediction of mortality among patients awaiting liver transplantation Gastroenterology 140 2011 1952 1960
25. T. Sersté, C. Francoz, F. Durand, P.E. Rautou, C. Melot, and D. Valla Beta-blockers cause paracentesis-induced circulatory dysfunction in patients with cirrhosis and refractory ascites: a cross-over study J Hepatol 55 2011 794 799